Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ImCheck Therapeutics closes €20mm Series A round

Executive Summary

Immuno-oncology start-up ImCheck Therapeutics SAS raised €20mm ($21.8mm) through its Series A round to investors including co-leads Boehringer Ingelheim Venture Fund, Kurma Partners, and Idinvest, which were joined by GIMV and Life Sciences Partners (LSP).
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies